top of page
Search

Saturn Minerals Inc. Announces Flow-Through Private Placement

VANCOUVER, BRITISH COLUMBIA–(Marketwired – July 25, 2016) – Saturn Minerals Inc. (TSX VENTURE:SMI)(FRANKFURT:SMK) (“Saturn” or the “Company”) is pleased to announce a flow-through financing as follows:

5,500,000 flow-through units at a price of $0.09 per unit (the “FT Unit”). Each FT Unit consists of one flow-through common share (the “FT Shares”) and 0.3636 non flow-through share purchase warrants (the “FT Warrants”). Each FT Warrant will entitle the holder to purchase one additional non flow-through common share, exercisable at a price of $0.15 per share for a period of 18 months from the date of issue of the FT Warrant. The FT Shares will entitle the holder to receive the tax benefits applicable to flow-through shares, in accordance with provisions of the Income Tax Act (Canada).

The FT Warrants are subject to an accelerated expiry if, at any time after an initial 4 month hold period expires, the closing price of Saturn’s common shares on the TSX Venture Exchange (the “TSXV”) exceeds $0.20 for any 20 consecutive trading days, in which event the holder will be given notice that the Warrants will expire 30 days following the date of such notice. The Warrants may be exercised by the holder during the 30-day period between the notice and the expiration of the Warrants.

All securities issued will be subject to a four-month hold period. The offering is subject to the approval of the TSXV. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities. Upon closing the Company will pay a finder’s fee of $29,700.00 to EMD Financial Inc. for their services in connection with the private placement.

Proceeds from the Private Placement will be used for to advance Saturn’s Saskatchewan oil & gas properties.

16 views0 comments

Recent Posts

See All

DiagnaMed Announces LIFE Offering of up to $650,000

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleas

Fobi AI Announces Completion of Non-Brokered Placement

VANCOUVER, BC, February 28, 2024, Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleas

Comentarios


bottom of page